Metraipolis › archive › dc_46febc6badeb
The implication of aberrant NRF2 activation in management of female cancers — Europe PMC PMID:41333220
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41333220
- DOI
- 10.3389/fonc.2025.1579135
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T12:38:57.382Z
- SHA-256 of the archived text
f531a6aa4c6268d65b2e5998b0c6ea7537902a9071b57b3da578de4a41b9a182- Stable URL of this page
https://metraipolis.com/documento/dc_46febc6badeb
How to cite
The implication of aberrant NRF2 activation in management of female cancers — Europe PMC PMID:41333220 — Europe PMC (en), https://europepmc.org/article/MED/41333220 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_46febc6badeb (Metraipolis archive dc_46febc6badeb, sha256 f531a6aa4c6268d65b2e5998b0c6ea7537902a9071b57b3da578de4a41b9a182)
BibTeX
@misc{dc46febc6badeb,
title = {The implication of aberrant NRF2 activation in management of female cancers — Europe PMC PMID:41333220},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41333220},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_46febc6badeb; sha256 f531a6aa4c6268d65b2e5998b0c6ea7537902a9071b57b3da578de4a41b9a182},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41333220. Agents can read the archived copy with the MCP tool read_document.